USFDA lens slow down Indian pharma exports, says CII official

Frequent inspections of Indian plants by the US FDA and subsequent observations slow down the growth of pharma exports even as US-China trade war presents huge opportunities for the drug industry, chairman of CII national committee on pharmaceuticals said G V Prasad said on Monday.

Prasad, also co-chairman and managing director ofDr Reddys Laboratories, said, It (effect of frequent inspections) is quite significant (on India pharma exports). Part of the slow-down is because of that."